glp-1 cardiovascular benefit disease continuum-GLP-1 action. Adapted from [46] SGLTi and GLP-1 in HF
Description
Alipanahi, B., Delong, A., Weirauch, M
![glp-1 cardiovascular benefit disease continuum-GLP-1 action. Adapted from [46] SGLTi and GLP-1 in HF](https://assets.radcliffecardiology.com/s3fs-public/article/2025-05/Figure3-Guideline-Recommendations.png?VersionId=HEwsyPwt7bPNVa1O9xXI4pMhddv6cw..)
Ask before you sign up if your medication will come labeled with a lot numberwhich identifies the compounding pharmacy and batch it comes fromor a different document called a certificate of analysis
Thats why we offer personalized, medically guided plans with GLP 1 & GIP weight loss medications, focusing on the right dosage for you, expert nutritional advice, and simple lifestyle changes to maximize your success
![glp-1 cardiovascular benefit disease continuum-GLP-1 action. Adapted from [46] SGLTi and GLP-1 in HF](https://www.bocamedicalcare.com/wp-content/uploads/2024/10/new-glp-desktop.jpg)
The needle is shorter, the injection depth is pre-set, and the dose is dialed rather than drawn
Short-acting ones (exenatide twice daily and lixisenatide) almost disappear from your blood between doses
![glp-1 cardiovascular benefit disease continuum-GLP-1 action. Adapted from [46] SGLTi and GLP-1 in HF](https://cdn.pace-cme.org/uploads/pce/radio/image/GLP-1-receptor-agonists-The-cardiovascular-benefits-beyond-glucose-control-2x.jpg)
No drug-related serious AEs, no AEs leading to discontinuation,no death, and no severe hypoglycemia events were reported
![glp-1 cardiovascular benefit disease continuum-GLP-1 action. Adapted from [46] SGLTi and GLP-1 in HF](https://www.mdpi.com/biomedicines/biomedicines-13-02595/article_deploy/html/images/biomedicines-13-02595-g005-550.jpg)